Skip to content
DataLookout
Menu

NCT07885488

Screening Elderly Adults in Rural Communities for Heart Failure Using an NT-proBNP-Guided Strategy in China (SEARCH-HF)

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Primary Outcome of Phase 1: New-incident heart-failure diagnosis
Timeframe: 6 months after baseline
Primary Outcome of Extension Study: Composite cardiovascular outcome
Timeframe: 18 months after baseline

Secondary (5)

Positive rate of heart failure
GDMT medication utilization rate
Proportion of participants with newly detected asymptomatic heart failure
Health economic evaluation
New-incident heart-failure diagnosis Using different NT-proBNP thresholds

Arms and interventions

Symptom-based heart failure screeningActive comparator

Participants with typical symptoms of heart failure, including dyspnea, chest tightness, fatigue, or lower-extremity edema, will be recommended for NT-proBNP and echocardiography to further evaluate heart failure.

NT-proBNP-guided heart failure screeningExperimental

Participants with an NT-proBNP level of 125 pg/mL or higher will be recommended to undergo further heart failure symptoms and echocardiographic evaluation for heart failure.

Diagnostic tests: Symptom-based heart failure screening, NT-proBNP-guided heart failure screening

Sites

1 site in 1 country

  • Hushu Community Health Service CenterNanjing, China